Skip to Main Content

Paper Details

Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study).
Am Heart J
19
2019
Author NameAffiliation
Henri JustinoTexas Children's Hospital
John L JefferiesThe Heart Institute, Cincinnati Children's Hospital Medical Centre
  • 1 - 2

Datasets

Release 1.2